Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesStocksEarnInstitutionAI & More
RUNE and ROSE Testing Major Support Amid Significant Correction: Is a Bounce Back Ahead?

RUNE and ROSE Testing Major Support Amid Significant Correction: Is a Bounce Back Ahead?

CoinsProbeCoinsProbe2025/02/08 21:11
By:Nilesh Hembade

Date: Sat, February 8, 2025 | 12:22 PM GMT

In the cryptocurrency market, major altcoins have been struggling to hold their ground since the November rally. Many altcoins have undergone a steep correction, largely influenced by the rapid rise in BTC dominance, which continues to add bearish pressure.

Among the hardest-hit altcoins are Thorchain (RUNE) and Oasis (ROSE), both of which have experienced substantial drops of 80% and 62%, respectively, in the past 60 days. Now, they are at a critical juncture, testing key support levels.

RUNE and ROSE Testing Major Support Amid Significant Correction: Is a Bounce Back Ahead? image 0 Source: Coinmarketcap

Thorchain (RUNE)

The monthly chart for Thorchain (RUNE) shows that the price has been consolidating within a three-year-long descending triangle pattern. The recent downtrend, which began on December 2, was triggered by a rejection from the upper resistance of the triangle at $7.58 after news of the protocol’s mounting debts .

RUNE and ROSE Testing Major Support Amid Significant Correction: Is a Bounce Back Ahead? image 1 Thorchain (RUNE) Monthly Chart/Coinsprobe (Source: Tradingview)

This decline brought RUNE to a major support zone, hitting a low of $0.95. However, the price has managed to hold and is now trading around $1.19.

Historically, this level has acted as a strong rebound zone, and if the pattern follows previous trends, RUNE may challenge the 100-day SMA as a key resistance. A breakout above this moving average could open the doors for a retest of the descending trendline.

Oasis (ROSE)

The weekly chart for Oasis (ROSE) shows consolidation within a descending triangle pattern. The recent downtrend, which started on December 2, was triggered by a rejection at the upper resistance trendline around $0.14.

RUNE and ROSE Testing Major Support Amid Significant Correction: Is a Bounce Back Ahead? image 2 Oasis (ROSE) Weekly Chart/Coinsprobe (Source: Tradingview)

This decline brought ROSE to a major support zone, hitting a low of $0.034. However, the price has managed to hold and is now trading around $0.040.

Previously, this level has acted as a strong rebound zone, and if the pattern follows previous trends, ROSE may challenge the 100-day SMA as a key resistance. A breakout above this moving average could open the doors for a retest of the descending trendline.

Is a Bounce Back Ahead?

Both RUNE and ROSE are showing resilience at their key support levels. Their next moves will largely depend on Ethereum (ETH), which is currently trading at $2,600, and the broader crypto market sentiment. If ETH continues its recovery, it could provide the momentum needed for altcoins like RUNE and ROSE to confirm a breakout and start a new bullish trend.

The MACD on both charts is bearish but showing signs of weakening momentum, indicating a potential reversal if a bullish crossover occurs. If buyers step in at these critical levels, both RUNE and ROSE could see a strong bounce in the coming weeks.

Investors should keep a close eye on these support levels, as a break below could trigger further downside, while a confirmed bounce could present an attractive entry point for long-term gains.

Disclaimer: This article is for informational purposes only and not financial advice. Always conduct your own research before investing in cryptocurrencies.

0
0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!

You may also like

Anthropic surged at market opening, everything seemed perfect! Then the situation suddenly changed, US stocks plunged—what happened?

On Thursday, Anthropic's largest-ever IPO debuted on the market, surging over 38% at the open, giving the appearance of a strong endorsement for AI trading. However, this celebration was short-lived—U.S. stocks opened high but closed lower throughout the day, with the S&P 500 ending down 2% and the Nasdaq falling 2.25%. Short-selling attacks on AMD, IPOs worth over $100 billion draining liquidity, and negative Gamma positions reaching five-year highs—all contributed to the AI feast turning into a stress test for the U.S. stock market.

华尔街见闻•2026/11/20 00:41

Anthropic's "super IPO": Over half of institutional investors didn't get a single share, while retail investors traded aggressively

More than 1,200 institutions competed to purchase Anthropic's IPO, with over half leaving empty-handed and almost all European investors missing out. Retail investors set a historical record for IPO trading volume since 2012, with a total transaction amount of $700-800 million, but this involved two-way trading rather than unilateral buying.

华尔街见闻•2026/11/20 00:36

US bank stocks sound the alarm! AI impact and the shadow of interest rate hikes loom, "death cross" reappears, indicating a possible prolonged decline

After experiencing their worst four-day losing streak since April 2025, major U.S. bank stocks have fallen into a "Death Cross" technical pattern, signaling bearish momentum.

智通财经•2026/11/19 23:51

Potentially the Biggest Deal in the Biopharmaceutical Industry in Recent Years! Sanofi (SNY.US) Plans Major Acquisition; Insmed (INSM.US) Stock Surges Over 20%!

According to informed sources, Sanofi is evaluating the possibility of acquiring the American pharmaceutical company Insmed. With the appointment of a new CEO, the French pharmaceutical company is actively seeking its next blockbuster drug.

智通财经•2026/11/19 23:22